Tomoo Nakagawa - Concepedia

Author

Tomoo Nakagawa

Also Known As

Akihiro Otsuka, Nakagawa, Tomoo, Ryota Hokari, T Nakagawa, T. Nakagawa, Tomoo NAKAGAWA, Tomoo Nakagawa, Tomoo Nakagawa, Yuji Naito, Yuki Ohta

177

Publications

2.7K

Citations

H-Index

101

Concepts

All Affiliations

Chiba University Chiba University Hospital Toho University Toho University Medical Center Sakura Hospital Tokyo Medical and Dental University

About

Tomoo Nakagawa is an author at Chiba University specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	25	802
2	Health Sciences	3	3	155
3	Engineering	2	2	112
4	Natural Sciences	1	1	87
5	Social Sciences	1	1	89

Tomoo Nakagawa

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial Takayuki Matsumoto, Satoshi Motoya, Kenji Watanabe, Journal of Crohn s and Colitis	2016	234
Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease Eiji Arai, Makoto Arai, Takuya Uchiyama, Brain Deep Brain StimulationNeurophysiologyLevodopa ResistanceGastroenterologyNeuropharmacology	2012	89
Analysis of Aldehydes in Water by Head Space-GC/MS. Naeko Sugaya, Tomoo Nakagawa, Katsumi Sakurai, JOURNAL OF HEALTH SCIENCE EngineeringBiological Mass SpectrometryChemistryChemical ContaminantOrganic Geochemistry	2001	87
Development of intestinal M cells and follicle-associated epithelium is regulated by TRAF6-mediated NF-κB signaling Takashi Kanaya, Sayuri Sakakibara, Toshi Jinnohara, The Journal of Experimental Medicine	2018	81
Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells Terry W. Moody, Samuel A. Mantey, Tapas K. Pradhan, Journal of Biological Chemistry	2004	79
A randomized placebo‐controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization Sadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka, Hepatology Endovascular TechniqueSurgeryPharmacotherapyHcc PatientsThrombosis	2017	78
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study Katsuyoshi Matsuoka, Mamoru Watanabe, Toshihide Ohmori, The Lancet. Gastroenterology & hepatology InflammationAnti-inflammatoryGastrointestinal PharmacologyImmunologyGastroenterology	2022	78
Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the <scp>DIAMOND</scp> trial Hiroshi Nakase, Satoshi Motoya, Tomohiro Matsumoto, Alimentary Pharmacology & Therapeutics	2017	76
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents Tomoaki Matsumura, Makoto Arai, Daisuke Maruoka, BMC Gastroenterology	2014	71
Mesenteric findings of CT enterography are well correlated with the endoscopic severity of Crohn’s disease Takehiro Sakurai, Tatsuro Katsuno, Keiko Saito, European Journal of Radiology Medical ImagingEndoscopic SeverityMedicineAbdominal ImagingGastroenterology	2016	65

Page 1